NCT00448721 2018-03-01
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
AEterna Zentaris
Phase 2 Completed
Clinical Trials
5 trialsNCT00498966 2018-02-05
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
AEterna Zentaris
Phase 2 Completed
NCT00058214 2015-02-23
Perifosine in Treating Patients With Recurrent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00399152 2014-02-19
Perifosine + Sunitinib Malate for Patients With Advanced Cancers
AEterna Zentaris
Phase 1 Completed
NCT00060437 2013-06-19
Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed